Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Development of a novel diabody for the targeted lysis of Hodgkin's lymphoma cells

June 11, 2014

Immune Design confirms first patient treated in phase I clinical trial of LV-305

June 10, 2014

Ventana Medical Systems and MedImmune collaborate on PD-L1 assay

June 10, 2014

First-in-human phase I study of RO-5520985 for advanced solid tumors

June 5, 2014

Altor Bioscience to study ALT-803 in combination with BCG for bladder cancer

June 3, 2014

Oncothyreon and Celldex Therapeutics to collaborate on trial of ONT-10 and varlilumab

June 2, 2014

Transgene discloses phase IIb data for TG-4010

May 30, 2014

Clinical evaluation of a dendritic cell-targeting vaccine for the treatment of refractory tumors

May 30, 2014

BMS and Incyte initiate phase I/II immunotherapy combination trial in cancer

May 29, 2014

Ganymed reports results from phase IIa gastroesophageal cancer trial

May 28, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...